KR930008974B1 - Method for preparation of fructosyl transferase & beta-galactosidase - Google Patents

Method for preparation of fructosyl transferase & beta-galactosidase Download PDF

Info

Publication number
KR930008974B1
KR930008974B1 KR1019910023739A KR910023739A KR930008974B1 KR 930008974 B1 KR930008974 B1 KR 930008974B1 KR 1019910023739 A KR1019910023739 A KR 1019910023739A KR 910023739 A KR910023739 A KR 910023739A KR 930008974 B1 KR930008974 B1 KR 930008974B1
Authority
KR
South Korea
Prior art keywords
galactosidase
fructosyltransferase
culture
activity
medium
Prior art date
Application number
KR1019910023739A
Other languages
Korean (ko)
Other versions
KR930013101A (en
Inventor
인만진
최경호
김민홍
황이남
Original Assignee
주식회사 미원
유영학
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 미원, 유영학 filed Critical 주식회사 미원
Priority to KR1019910023739A priority Critical patent/KR930008974B1/en
Publication of KR930013101A publication Critical patent/KR930013101A/en
Application granted granted Critical
Publication of KR930008974B1 publication Critical patent/KR930008974B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A mutant producing the fructosyl transferase and beta- galactosidase is screened by UV treatment of the parent strain Aureobasidium pullulans (NRRL Y-2567). For production of the enzymes, the mutant was cultured at 25-35 deg.C in a nutrient medium containing sucrose or lactose as a carbon source at neutral pH range, under aerobic condition. IPTG (2.0-10mM) was added into the medium to induce production of the enzymes.

Description

프락토실트랜스퍼라제 및 β-갈락토시다제의 제조방법Method for preparing fructosyltransferase and β-galactosidase

본 발명은 오레오바시디움(Aureobasidium)속에 속하는 미생물 변이주 오레오바시디움 플루란스(Aureobasidium pullulans)를 특정 탄소원을 포함하는 영양배지중에서 호기적으로 배양하여 프락토실트랜스퍼라제(fructosyl transferase) 또는 β-갈락토시다제(β-galactosidase)를 균체내 및 배양액에 축적시키고, 그로부터 프락토실트랜스퍼라제 또는 β-갈락토시다제를 회수함을 특징으로 하는 프락토실트랜스퍼라제 또는 β-갈락토시다제의 제조방법에 관한 것이다.The present invention is characterized by aerobic culture of microorganism strain Aureobasidium pullulans belonging to the genus Aureobasidium (Aureobasidium pullulans) aerobic culture in a nutrient medium containing a specific carbon source fructosyl transferase or β-galacto Preparation of fructosyltransferase or β-galactosidase, characterized by the accumulation of β-galactosidase in cells and in the culture medium, from which fructosyltransferase or β-galactosidase is recovered. It is about a method.

프락토실트랜스퍼라제는 프락토스 1분자를 다른 프락토스에 β(1,2)위치로 전이, 결합시키는 성질을 갖는 효소로 오레오바시디움(Aureobasidium)속, 아스퍼질러스(Aspergillus)속, 푸사리움(Fusarium)속 등의 미생물과 아스파라거스, 돼지감자등과 같은 식물체로부터 얻을 수 있다.Fructosyltransferase is an enzyme that transfers and binds one molecule of fructose to the β (1,2) position to another fructose. The genus Aureobasidium, Aspergillus, and Fusarium It can be obtained from microorganisms such as the genus Fusarium and plants such as asparagus and swine potatoes.

일반적으로 이 효소의 과당전이능을 이용하여, 설탕에 과당이 1∼4개 결합된 구조로 되어 있고 난소화성, 충치예방에 효능이 있는 비피더스 증식 활성이 있고 저칼로리 감미료, 건강식품, 동물사료, 의약품등으로 널리 사용되고 있는 프락토올리고당을 제조한다.In general, by using the fructose metastasis of this enzyme, it has a structure in which 1 to 4 fructose is combined with sugar, has a bifidus proliferative activity that is indigestible and effective in preventing tooth decay, and is a low-calorie sweetener, health food, animal feed, and pharmaceuticals. The fructooligosaccharide which is widely used by the above is manufactured.

한편 β-갈락토시다제는 유당(lactose)를 분해하여 포도당과 갈락토스로 분해하는 기능을 갖는 효소로 기원에 따라 갈락토스의 전이활성을 갖기도 한다.On the other hand, β-galactosidase is an enzyme having a function of degrading lactose to glucose and galactose, and also has a transacting activity of galactose depending on its origin.

β-갈락토시다제는 아스퍼질러스(Aspergillus)속, 페니실륨(Penicillum)속 등과 같은 곰팡이, 대장균, 스트렙토코커스(Steptococcus)속, 락토바실러스(Lactobacillus)속, 비피도박테리움(Bifidobacterium)등과 같은 박테리아와 클류베로마이세스(Kluyveromyces)속, 캔디다(Candida)속 등과 같은 효모로부터 얻을 수 있다.β-galactosidase is a fungus such as the genus Aspergillus, genus Penicillum, E. coli, Streptococcus, Lactobacillus, Bifidobacterium, etc. It can be obtained from bacteria and yeasts such as the genus Kluyveromyces and Candida.

본 발명자들 상기의 두효소가 다음과 같은 공통적인 특징을 갖는다는 사실을 알았다.The inventors have found that the two enzymes have the following common characteristics.

1) 두 효소는 기질의 글라이코사이드 결합을 분해한다.1) Both enzymes break down glycoside bonds of the substrate.

2) 두 효소는 글라이코사이드 결합의 분해로 생성된 단당(프락토스 홈은 갈락토스)를 또다른 기질에 전이시켜 β-결합을 만든다.2) Both enzymes transfer β-bonds by transferring sugars (fractose grooves, galactose) produced by the breakdown of glycoside bonds to another substrate.

이로 미루어보아 두효소의 작용기작도 서로 유사하리라 예상되어 진다.Thus, it is expected that the mechanism of action of the two enzymes will be similar.

이러한 상황하에서 본 발명자들은 상기의 두가지 효소를 하나의 균주에서 생산할 수 있도록 하기 위하여 오랜 연구를 수행하였고 그 결과 오레오바시디움 풀루란스 변이주를 이용하여 이와 같은 목적을 달성할 수 있음을 발견하고 본 발명을 완성하였다.Under these circumstances, the present inventors have conducted a long research to produce the above two enzymes in one strain, and as a result, have discovered that the above object can be achieved by using an oreovacsidium pullulan mutant strain. Completed.

즉, 본 발명은 배지중의 탄소원의 종류에 따라 프락토실트랜스퍼라제 또는 β-갈락토시다제를 선택적으로 생산할 수 있는 오레오바시디움 풀루란스 변이주를 배양하여 프락토실트랜스퍼라제 또는 β-갈락토시다제를 제조하는 방법을 제공한다.That is, the present invention is cultured orocobadium pullulans mutants capable of selectively producing fructosyltransferase or β-galactosidase according to the type of carbon source in the medium, fructosyltransferase or β-galacto Provided is a method for preparing a sidase.

이하, 본 발명을 좀더 상세히 설명하면 다음과 같다.Hereinafter, the present invention will be described in more detail.

본 발명에 따른 오레오바시디움 플루란스 변이주는 다음과 같이 제조할 수 있다.Oreobashdium flulans variance according to the present invention can be prepared as follows.

친주인 오레오바시디움 플루란스(NRRL Y-2567)을 설탕 6%, 효모 엑기스 0.3%, 제 2 인산칼륨 0.5%, 염화나트륨 0.1%, 질산암모늄 0.06% 및 황산마그네슘 0.02%를 함유하는 배지 1(pH 6.8, 120℃×20분 살균)에서 36∼48시간 동안 배양한 후, 원심분리하여 상등액과 균체를 분리하고 상등액은 버린 뒤 멸균한 0.05M 인산완충용액(pH 6.8)에 현탁시킨 다음 15W 자외선등으로 30cm 거기에서 30분간 노출시켜 변이를 유발하였다. 자외선 변이 유발후 생존율은 0.1∼0.5%이었다. 그런 후 감자 침출물 20%, 포도당 2% 및 한천 1.5%를 함유하는 배지 2(120℃×20분 살균)에 도말하고 30℃에서 60∼84시간 동인 배양한 다음 분리된 콜로니를 플라스크에 액체 배양하여 증식시켜 1차 변이주를 얻었다.Parent Oreobacidium flulans (NRRL Y-2567) was prepared in medium 1 (pH) containing 6% sugar, 0.3% yeast extract, 0.5% dibasic potassium phosphate, 0.1% sodium chloride, 0.06% ammonium nitrate and 0.02% magnesium sulfate. 6.8, 120 ℃ × 20 minutes sterilization) for 36 to 48 hours, then centrifuged to separate the supernatant and bacteria, discard the supernatant and suspended in sterilized 0.05M phosphate buffer (pH 6.8) and then 15W ultraviolet light 30 cm exposure there for 30 minutes to cause mutations. Survival after UV mutation was 0.1-0.5%. Then, plate in medium 2 (120 ° C. × 20 min sterilization) containing 20% potato leach, 2% glucose and 1.5% agar, incubate for 60 to 84 hours at 30 ° C., and then culture the separated colonies in a flask. By multiplying to obtain a primary mutant strain.

1차 변이주를 상기 배지 2에 다시 배양하여 얻은 클로니를 살균한 0.05M 인산완충용액(pH 6.8)에 잘 현탁한 후 50g/ml 농도의 N-메틸-N'-니트로-N-니토로스-구아니딘용액 2ml를 첨가하여 실온에서 30분간 진탕시킨 후 원심분리 및 세척에 의하여 균체와 변이제를 분리시킨 후 배지 2에 평판이식 후 30℃에서 60∼84시간 동안 배양후 생육이 우수한 클로니를 2차 변이주로 얻었다.The primary mutant was resuspended in medium 2, and the suspension of the clonie was well suspended in sterile 0.05M phosphate buffer solution (pH 6.8), followed by N-methyl-N'-nitro-N-nitorose- at a concentration of 50 g / ml. After adding 2 ml of guanidine solution and shaking for 30 minutes at room temperature, the cells and the mutant were separated by centrifugation and washing, and then plated in medium 2, and then cultured at 30 ° C. for 60 to 84 hours, and then the chlorine was excellent. Got a tea variation.

이렇게 얻은 2차 변이주들을 설탕 20%, 옥수수 첨지액 5%, 제 2인산칼륨 0.5%, 질산나트륨 1% 및 황산마그네슘 0.05%를 함유하는 배지 3(pH 6.8,120℃×20분 살균) 및 유당 10%, 펩톤 1.5%, 효모 엑기스 0.5%, 제 1인산칼름 0.5%, 질산나트륨 0.2%, 황산마그네슘 0.05% 및 염화칼슘 0.05%를 함유하는 배지 4(pH 6.0,120℃×20분 살균)에서 각각 배양하여 프락토실트랜스퍼라제와 β-갈락토시다제의 활성이 모두 높은 변이주를 선별하고 MW-4218로 명명하였다.The secondary mutants thus obtained were treated with medium 3 (pH 6.8, 120 ° C. × 20 min sterilization) and lactose containing 20% sugar, 5% corn steep solution, 0.5% dibasic potassium phosphate, 1% sodium nitrate and 0.05% magnesium sulfate. 10%, peptone 1.5%, yeast extract 0.5%, monobasic phosphate 0.5%, sodium nitrate 0.2%, magnesium sulfate 0.05% and calcium chloride 0.05%, respectively (pH 6.0, 120 ℃ x 20 minutes sterilization) Variants with high activity of both fructosyltransferase and β-galactosidase were selected and named MW-4218.

본 발명에 따른 변이주 오레오바시디움 플루란스 MW-4218은 1991년 12월 20일자로 한국종균협회(KFCC)에 (KFCC)-10754의 기탁번호로 기탁되어 있다.Variation strain Oreobashdium flulans MW-4218 according to the present invention was deposited on December 20, 1991 with the deposit number of (KFCC) -10754 to the Korean spawn association (KFCC).

본 발명의 변이주는 다음과 같은 균주특성을 갖는 것이 관찰되었다.Mutant strain of the present invention was observed to have the following strain characteristics.

1) 생육환경에 따라 균체의 형태가 포자→균사형태→효모형태→균사형태→포자로 변하는 불완전 균류이다. 즉, 초기에는 포자에서 발아하여 균사체 형태로 성장하다 시간이 경과함에 따라, 또 주위 생육환경이 호전되면 효모형태로 급속히 성장한다.1) It is an incomplete fungus in which the form of mycelium changes from spores to mycelium form → yeast form → mycelium form → spores depending on the growth environment. That is, in the early stage, germination of spores grows in the form of mycelium, and as time passes, the surrounding growth environment improves rapidly and grows in the yeast form.

영양소가 고갈되거나, 세포내외에 대사물질이 축적되면 다시 균사체 형태로 성장을 전환하며 결국은 포자를 형성하게 된다.Depletion of nutrients or accumulation of metabolites inside and outside the cells converts the growth back to mycelium form, eventually forming spores.

2) 대수성장기, 즉 효모형태로 성장할 시기에 균체형태는 원형 혹은 타원형으로 효소의 생산 및 분비가 활발하며, 환경적인 스트레스를 받는 생육후반기에는 다당류를 생성, 분리하여 배양액의 점도가 급속히 증가한다.2) In the growth phase of logarithmic growth, that is, the yeast form, the cell type is circular or oval, and the production and secretion of enzymes is active, and in the second half of growth under environmental stress, polysaccharides are produced and separated to increase the viscosity of the culture solution rapidly.

3) 생육초기 및 대수성장기에는 노란색 또는 살색의 색깔을 보이다가 생육후인기에 갈색, 검은색의 색소를 형성한다. 이때 생성하는 색소는 배양액의 pH 조건에 따라 크게 달라지는데 pH가 중선부근이면 살색 또는 노란색을 나타내며, 약산성부근이면 갈색의 색소를 생산한다. 또, 생육 온도에 따라서도 달라지는데 온도가 25℃ 부근일 경우 색소의 생산이 왕성하다.3) In the early stage of growth and logarithmic growth, yellow or flesh-colored color is formed, and then brown and black pigment is formed in the stage of growth. At this time, the pigment to be produced varies greatly depending on the pH conditions of the culture medium, the pH is near the midline to show flesh or yellow, and the weakly acidic to produce a brown pigment. In addition, it varies depending on the growth temperature, but when the temperature is around 25 ℃, the production of pigments is vigorous.

4) 배양액의 탄소원의 종류에 따라 주로 생산되는 효소가 달라지게 된다. 즉, 탄소원을 설탕, 원당, 당밀처럼 슈크로스가 주를 이루는 탄소원을 사용하게 될 경우 생성되는 효소는 주로 프락토실트랜스퍼라제이며 유당, 유장분말등 처럼 락토스를 주된 탄소원으로 사용하는 경우는 β-갈락토시다제를 주로 생산한다.4) The enzymes produced vary depending on the type of carbon source of the culture. In other words, if the carbon source uses a carbon source composed mainly of sucrose, such as sugar, raw sugar, and molasses, the enzyme produced is mainly fructosyltransferase. When lactose is used as a main carbon source, such as lactose and whey powder, β- Mainly produces galactosidase.

5) 친주와 비교하여 프락토실트랜스퍼라제의 활성은 큰 변화가 없는 반면 β-갈락토시다제의 경우는 가수분해 활성 및 전이활성이 크게 증가한 것으로 나타났다.5) Compared with parent strain, the activity of fructosyltransferase did not change significantly, whereas β-galactosidase showed a significant increase in hydrolytic and metastatic activity.

본 발명의 변이주의 배양에 사용할 수 있는 탄소원은 앞서 언급한 것처럼 배양목적, 즉 얻고자 하는 효소의 종류에 따라서 슈크로스-함유 탄소원 또는 유당-함유 탄소원을 선택할 수 있으며, 질소원으로는 유기, 무기의 질소원 예를들면, 효모엑기스, 옥수수 침지액, 펩톤, 질산나트륨, 질산암모늄, 폴리펩톤 및 아미노산등을 사용할 수 있다.As mentioned above, the carbon source that can be used for culturing the mutant strain of the present invention may select a sucrose-containing or lactose-containing carbon source according to the purpose of culture, that is, the type of enzyme to be obtained. Nitrogen sources such as yeast extract, corn steep liquor, peptone, sodium nitrate, ammonium nitrate, polypeptone and amino acids can be used.

또한, 미네랄 및 무기염류로는 황산마그네슘, 염화나트륨, 인산 제 1칼륨 및 인산 제 2칼륨 등을 사용할수 있다.Moreover, magnesium sulfate, sodium chloride, a first potassium phosphate, a second potassium phosphate, etc. can be used as mineral and inorganic salts.

본 변이주의 배양온도는 25∼35℃의 범위가 적당하며, 바람직하기로는 28∼32℃의 범위이며 배양에 최적인 pH는 중성부근이다.The culture temperature of the mutant strain is suitable in the range of 25 to 35 ° C, preferably in the range of 28 to 32 ° C, and the optimum pH for culturing is near neutral.

이상의 조건으로 배양하면 탄소원의 종류에 따라 프락토실트랜스퍼라제는 또는 β-갈락토시다제가 균체내 및 배양액에 축적된다.When cultured under the above conditions, fructosyltransferase or β-galactosidase accumulates in the cells and in the culture medium depending on the type of carbon source.

효소의 활성측정에서 프락토실트랜스퍼라제의 활성은 효소전이반응에 의하여, 유리, 생성된 포도당의 양을 포도당 산화법으로 측정하여 결정하였으며, 기질농도는 60%(w/v), 온도 55℃, pH 5.5인 조건하에서 분단 1μmole의 포도당을 생성하는 효소의 양을 1unit로 정의하였다.In the enzyme activity measurement, the activity of fructosyltransferase was determined by measuring the amount of free and produced glucose by the enzyme oxidation reaction, and the glucose concentration was determined by the glucose oxidation method. The substrate concentration was 60% (w / v), the temperature was 55 ° C, Under the condition of pH 5.5, the amount of enzyme that produces 1 μmole of glucose was defined as 1 unit.

β-갈락토시다제의 활성은 O-나이트릴페닐-β-갈락토사이드(ONPG)를 기질로 하여 염화칼슘 0.05%, pH 6.0, 120℃×20분 살균, 기질농도 5mM ONPG, 온도 55℃, pH 6.5인 조건하에서 1분당 1μmole의 O-나이트로페놀을 생성하는 효소의 양을 1unit로 정의하였다.The activity of β-galactosidase was calculated by using O-nitrilephenyl-β-galactoside (ONPG) as a substrate, 0.05% calcium chloride, pH 6.0, 120 ° C x 20 minutes sterilization, substrate concentration 5mM ONPG, temperature 55 ° C, The amount of enzyme that produces 1 μmole of O-nitrophenol per minute under pH 6.5 was defined as 1 unit.

β-갈락토시다제의 활성은 또한 유당을 기질로 하여 측정할 수도 있다. 이때 기질농도는 10%(w/v)하여 ONPG의 경우와 동일한 조건에서 반응한 후 생성된 포도당의 양을 포도당 산화법으로 측정하고 분당 1μmole의 포도당을 생성하는 효소량을 1unit로 정의하였다. 또한 갈락토스의 농도는 HPLC로 분석, 정량하였다.The activity of β-galactosidase can also be measured using lactose as a substrate. At this time, the substrate concentration was 10% (w / v) and reacted under the same conditions as in the case of ONPG. The amount of glucose produced was measured by glucose oxidation, and the amount of enzyme that produced 1 μmole of glucose per minute was defined as 1 unit. In addition, the concentration of galactose was analyzed and quantified by HPLC.

이하 실시예에 의해 본 발명을 보다 상세히 설명하지만 본 발명이 이들 실시예에 한정되는 것은 아니다.The present invention will be described in more detail with reference to the following Examples, but the present invention is not limited to these Examples.

[실시예 1]Example 1

〈발아배양〉〈G germination Culture〉

50ml의 배지 1을 250ml 용량의 진탕용 삼각플라스크에 넣어 120℃에서 20분간 살균한 후 오레오바시디움 풀루란스 MW-4218(KFCC 10754)를 1백금이 접종한 후 30℃에서 회전 진탕시키면서 36시간 배양하였다.50 ml of medium 1 was placed in a 250 ml shaking Erlenmeyer flask and sterilized at 120 ° C. for 20 minutes, inoculated with platinum of Oreobashdium pullulans MW-4218 (KFCC 10754), and incubated for 36 hours with rotation shaking at 30 ° C. It was.

〈전배양〉〈All Cultures〉

100ml의 배지 1을 함유하는 500ml 용량의 진탕용 삼각플라스크에 상기 발아배양에서 얻은 배양액을 5%(v/v)로 식균하고 발아배양과 동일한 조건으로 24시간 배양한 다음 종균으로 사용하였다.The culture solution obtained in the germination culture was inoculated at 5% (v / v) in a 500 ml shaking Erlenmeyer flask containing 100 ml of medium 1, and cultured for 24 hours under the same conditions as the germination culture, and then used as a spawn seed.

〈본배양〉<Main culture>

앞서 얻은 종균을 5%(v/v) 농도로 배지 3을 함유하는 1ℓ용량의 진탕 플라스크에 무균적으로 접종하였다. 그런 다음 발아배양과 동일한 조건으로 25시간 배양하였다. 배양 완료 후 균체 내,외에 생성된 프락토실트랜스퍼라제의 활성은 배양액 ml당 400∼450unit이었다.The previously obtained seed was aseptically inoculated into a 1 L shake flask containing medium 3 at a concentration of 5% (v / v). Then incubated for 25 hours under the same conditions as the germination culture. After completion of the culture, the activity of the produced fructosyltransferase in and outside the cells was 400 to 450 units per ml of culture medium.

[실시예 2]Example 2

〈발아배양〉〈G germination Culture〉

배지 2에서 생육시킨 오레오바시디움 풀루란스 MW-428(KFCC 10754) 콜로니 1백금이를 유당 5%, 포도당 1%, 펩톤 0.5%, 제 1인산칼륨 0.5% 및 황산마그네슘 0.02%를 함유하는 배지 5(pH 6.0, 120℃ × 20분 살균)를 50ml 함유하는 진탕용 삼각플라스크에 무균적으로 접종한 후 30℃에서 48시간 배양하였다.Oreobasidium pullulan MW-428 (KFCC 10754) colony grown in Medium 2 was a medium containing 5% lactose, 1% glucose, 0.5% peptone, 0.5% potassium monophosphate and 0.02% magnesium sulfate. After aseptically inoculated into a shaking Erlenmeyer flask containing 50 ml (pH 6.0, 120 ℃ × 20 minutes sterilization) and incubated at 30 ℃ 48 hours.

〈전배양〉〈All Cultures〉

100ml의 배지 5을 함유하는 500ml 용량의 진탕용 삼각플라스크에 상기 발아배양에서 얻은 배양액을 5%(v/v)로 식균하고 발아배양과 동일하게 24시간 배양하여 종균으로 사용하였다.The culture solution obtained in the germination culture was inoculated at 5% (v / v) in a 500 ml shaking Erlenmeyer flask containing 100 ml of medium 5, and cultured for 24 hours in the same manner as the germination culture, and used as a spawn seed.

〈본배양〉<Main culture>

앞서 얻은 종균을 5%(v/v) 농도로 200ml의 배지 4를 함유하는 1ℓ용량의 진탕플라스크에 접종한 후 발아배양과 동일하게 48∼60시간 배양하였다. 배양 후 생성된 β-갈락토시다제의 활성은 ml당 10∼20unit이었다.The seed spawn obtained above was inoculated in a 1 L shake flask containing 200 ml of medium 4 at a concentration of 5% (v / v), and then cultured for 48 to 60 hours in the same manner as in germination culture. The activity of β-galactosidase produced after the culture was 10-20 units per ml.

[실시예 3]Example 3

실시예 2와 동일하게 실시하되, 본 배양의 대수 증식기에 β-갈락토시다제의 생성을 유도하기 위한 유도체로 알려진 이소프로필-β-티오갈락토퓨라노사이드(IPTG)를 0.5∼10mM의 농도로 첨가하여 배양하였다,In the same manner as in Example 2, the concentration of isopropyl-β-thiogalactofuranoside (IPTG), known as a derivative for inducing the production of β-galactosidase during the logarithmic growth phase of the present culture, was 0.5-10 mM. Cultured by addition of

IPTG의 농도에 따른 배양액의 효소활성을 측정하고 결과를 표 1에 나타내었다.The enzyme activity of the culture medium according to the concentration of IPTG was measured and the results are shown in Table 1.

[표 1] IPTG 농도별 β-갈락토시다제의 활성Table 1 Activity of β-galactosidase by IPTG Concentration

[실시예 4]Example 4

본 발명의 변이주 오레오바시디움 풀루란스 MW-4218대신에 친주인 NRRL Y-2567을 이용하여 실시예 1 및 실시예 2와 동일하게 배양하여 효소를 얻은 후 그 활성을 비교하고 결과를 표 2에 나타내었다.The enzymes were obtained by culturing in the same manner as in Example 1 and Example 2 using NRRL Y-2567, which is a parent strain instead of the variant strain Oreobashicium pullulan MW-4218 of the present invention, and the results are shown in Table 2. It was.

[표 2]TABLE 2

상기 표 2의 결과에서 알 수 있듯이, 본 발명이 변이주는 친주에 비해 약 7∼8배 높은 β-갈락토시다제 생성능을 나타낸다.As can be seen from the results of Table 2, the present invention shows a β-galactosidase generating ability about 7 to 8 times higher than the parent strain.

[실시예 5]Example 5

실시예 2에서 얻은 β-갈락토시다제의 가수분해 활성과 전이활성을 유당을 기질로 하여 측정하였다. 한편, 친주인 NRRL Y-2567을 동일하게 배양하여 β-갈락토시다제를 얻고, 이에 대해 각각의 활성을 측정하고 비교하였다. 가수분해활성과 전이활성을 각각 가수분해율과 전이율로 표기하여 결과를 표 3에 나타내었다.The hydrolytic and transition activities of β-galactosidase obtained in Example 2 were measured using lactose as a substrate. Meanwhile, NRRL Y-2567, a parent strain, was cultured in the same manner to obtain β-galactosidase, and their activities were measured and compared. Hydrolysis activity and transition activity are expressed by the hydrolysis rate and the transfer rate, respectively, and the results are shown in Table 3.

[표 3]TABLE 3

상기 표 3의 결과에서 알 수 있듯이, 본 발명의 변이주가 생산하는 β-갈락토시다제는 친주에 의해 생산되는 β-갈락토시다제에 비해 2배이상 높은 가수분해 활성 및 7배 높은 전이활성을 나타낸다.As can be seen from the results of Table 3, the β-galactosidase produced by the mutant strain of the present invention is at least 2 times higher hydrolytic activity and 7 times higher transfer activity than the β-galactosidase produced by the parent strain. Indicates.

Claims (3)

탄소원의 종류에 따라 프락토실트랜스퍼라제 또는 β-갈락토시다제를 생산할 수 있는 오레오바시듐 풀루란스(Aureobasidium pullulans) MW-4218(KFCC 10754)을 탄소원으로 각각 설탕 또는 유당을 함유하는 영양배지에서 25∼35℃, 중성 pH에서 호기적으로 배양하여 균체내 또는 배양액중에 프락토실트랜스퍼라제 또는 β-갈락토시다제를 축적시킨후 그로부터 이들 효소를 회수함을 특징으로 하는 프락토실트랜스퍼라제 및 β-갈락토시다제의 제조방법.Aureobasidium pullulans MW-4218 (KFCC 10754), which can produce fructosyltransferase or β-galactosidase, depending on the type of carbon source, is used as a carbon source in a nutrient medium containing sugar or lactose, respectively. Fructosyltransferase, characterized by accumulating fructosyltransferase or β-galactosidase in cells or in culture by aerobic incubation at 25 to 35 ° C. and neutral pH, and recovering the enzyme therefrom. Method for producing β-galactosidase. 제 1 항에 있어서, β-갈락토시다제를 생산하는 경우에는 β-갈락토시다제 생산 유도제인 이소프로필-β-티오갈락토퓨라노사이드(IPTG)를 2.0∼10mM의 농도로 첨가함을 특징으로하는 프락토실트랜스퍼라제 및 β-갈락토시다제의 제조방법.The method according to claim 1, wherein when producing β-galactosidase, isopropyl-β-thiogalactofuranoside (IPTG), which is a β-galactosidase production inducer, is added at a concentration of 2.0 to 10 mM. A method for producing fructosyltransferase and β-galactosidase. 제 1 항에 있어서, 생산된 β-갈락토시다제의 전이활성이 가수분해 활성의 50% 이상임을 특징으로 하는 프락토실트랜스퍼라제 및 β-갈락토시다제의 제조방법.The method for producing fructosyltransferase and β-galactosidase according to claim 1, wherein the produced β-galactosidase has a transition activity of 50% or more of the hydrolytic activity.
KR1019910023739A 1991-12-21 1991-12-21 Method for preparation of fructosyl transferase & beta-galactosidase KR930008974B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019910023739A KR930008974B1 (en) 1991-12-21 1991-12-21 Method for preparation of fructosyl transferase & beta-galactosidase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019910023739A KR930008974B1 (en) 1991-12-21 1991-12-21 Method for preparation of fructosyl transferase & beta-galactosidase

Publications (2)

Publication Number Publication Date
KR930013101A KR930013101A (en) 1993-07-21
KR930008974B1 true KR930008974B1 (en) 1993-09-17

Family

ID=19325432

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910023739A KR930008974B1 (en) 1991-12-21 1991-12-21 Method for preparation of fructosyl transferase & beta-galactosidase

Country Status (1)

Country Link
KR (1) KR930008974B1 (en)

Also Published As

Publication number Publication date
KR930013101A (en) 1993-07-21

Similar Documents

Publication Publication Date Title
WO2001090335A1 (en) Novel cyclodextrin glucanotransferase, process for producing the same and process for producing cyclodextrin by using this enzyme
US5294546A (en) Method for production of a growth factor for Bifidobacterium sp.
US6984406B2 (en) Bacillus sp. WL-1 strain producing mannanase
US5057418A (en) Process for the preparation of difructose dianhydride iii
KR930008974B1 (en) Method for preparation of fructosyl transferase &amp; beta-galactosidase
HU181488B (en) Process for the hydrolysis of racemic hydantoins into optically active n-carbamoyl-aminoacid derivatives and for preparing the hydrolyzing enzymatic complex
FI110518B (en) Levan sucrose enzyme, process for its preparation, microorganisms producing it and compositions containing it
EP0424500A1 (en) Novel cell wall lytic enzymes from bacillus pabuli.
KR890001127B1 (en) Producing method for oligo-fructose
KR100303066B1 (en) Streptococcus sp. microorganism producing hyaluronic acid
JP3556704B2 (en) β-galactosidase
JPH10165192A (en) Production of neofructooligosaccharide
KR0139591B1 (en) The microorganism which produces high efficiency beta-galactosidase and method for producing beta-galactosidase
WO2021086080A1 (en) Method for producing maltotetraose-containing oligosaccharides
KR890003678B1 (en) Process for preparing fructosyl-transferase by microorganism
EP0262858B1 (en) Method for production of a growth factor for bifidobacterium Sp.
KR970000587B1 (en) Microorganism producing gmp
KR890000539B1 (en) Process for preparing 5&#39;-guanylic acid using microorganism
KR0129471B1 (en) Preparation method of amylase producing maltotetraose
JPH0795947B2 (en) Method for producing α-1,3-glucanase
JP4197604B2 (en) Novel strain, novel α-glucosidase and method for producing the same
KR100317021B1 (en) Microorganism bacillus sp. producing fructosyltransferase and method for producing oligosaccharides using the same
KR890000537B1 (en) Process for preparing 5&#39;guanylic acid through fermentation
KR100467956B1 (en) Novel Bacillus polymixa MGL21 strain, DNA producing cycloinulooligosaccharide fructanotransferase, method for producing cycloinulooligosaccharide fructanotransferase from it and for cyclofructan thereof
KR100424846B1 (en) 5&#39;-inosinic acid producing microorganism and the process for production thereof

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19990911

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee